Showing results (91-100 of 119) with videos related to

Sort By:
Pageof 12
Cell Reports|April 26, 2018
Multiplexed Quantitation of Intraphagocyte Mycobacterium tuberculosis Secreted Protein EffectorsFadel Sayes, Catherine Blanc, Louis S Ates, et al.
Journal of Virology|July 24, 2015
Polyphenols Inhibit Hepatitis C Virus Entry by a New Mechanism of ActionNoémie Calland, Marie-Emmanuelle Sahuc, Sandrine Belouzard, et al.
Plos Pathogens|March 8, 2023
Tirap controls Mycobacterium tuberculosis phagosomal acidificationImène Belhaouane, Amine Pochet, Jonathan Chatagnon, et al.
Cell Reports|September 28, 2017
Mycobacterium tuberculosis Controls Phagosomal Acidification by Targeting CISH-Mediated SignalingChristophe J Queval, Ok-Ryul Song, Jean-Philippe Carralot, et al.
Plos One|November 10, 2011
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatisAna Luisa de Jesus Lopes Ribeiro, Giulia Degiacomi, Fanny Ewann, et al.
Scientific Reports|May 12, 2018
Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticlesJoana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
Scientific Reports|July 16, 2017
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticlesJoana Costa-Gouveia, Elisabetta Pancani, Samuel Jouny, et al.
Plos Biology|April 29, 2024
A host-directed oxadiazole compound potentiates antituberculosis treatment via zinc poisoning in human macrophages and in a mouse model of infectionAlexandra Maure, Emeline Lawarée, Francesco Fiorentino, et al.
Journal of Medicinal Chemistry|November 22, 2011
Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitorsMarion Flipo, Matthieu Desroses, Nathalie Lecat-Guillet, et al.
Journal of Medicinal Chemistry|July 24, 2023
Design, Synthesis, and Evaluation of Novel Δ<sup>2</sup>-Thiazolino 2-Pyridone Derivatives That Potentiate Isoniazid Activity in an Isoniazid-Resistant <i>Mycobacterium tuberculosis</i> MutantSouvik Sarkar, Anne E Mayer Bridwell, James A D Good, et al.
Pageof 12